UPDATE: Citigroup Reiterates on Medtronic Following Solid F2Q14 Results
November 21, 2013 at 10:25 AM EST
In a report published Thursday, Citigroup analyst Matthew J. Dodds reiterated a Buy rating on Medtronic (NYSE: MDT ), and raised the price target from $62.00 to $69.00. In the report, Citigroup noted, “F2Q14 results were slightly ahead of Street expectations driven by ICD upside, lower non-operating expense and a
